Janssen Submits Application to U.S. FDA Seeking Approval of ERLEADA ® (apalutamide) for Patients with Metastatic Castration-Sensitive Prostate Cancer

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news